Evidence map›Paper›PMID 29944741›Full record

ArticleAnnals of neurology2018

Combined neuropathological pathways account for age-related risk of dementia.

Melinda C Power, Elizabeth Mormino, Anja Soldan, Bryan D James, Lei Yu, Nicole M Armstrong, Katherine J Bangen, Lisa Delano-Wood, Melissa Lamar, Yen Ying Lim and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Annals of neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 2 pooled it
15.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 2 syntheses or guidelines pooled it, 214 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Vascular cognitive impairment and dementia: Prevention, treatments, mechanisms and management options for the future.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Brain and retina in Alzheimer's disease: Pathological intersections and estimates from imaging.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 2 countries.

Melinda C PowerDepartment of Epidemiology and Biostatistics, George Washington University Milken Institute School of Public Health, Washington, DC.
Elizabeth MorminoDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Anja SoldanDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.
Bryan D JamesRush Alzheimer's Disease Center, Rush University, Chicago, IL.
Lei YuDepartment of Neurological Sciences, Rush University, Chicago, IL.
Nicole M ArmstrongDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Katherine J BangenVA San Diego Healthcare System, San Diego, CA.
Lisa Delano-WoodVA San Diego Healthcare System, San Diego, CA.
Melissa LamarRush Alzheimer's Disease Center, Rush University, Chicago, IL.
Yen Ying LimFlorey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia.
Kelly NudelmanDepartment of Radiology and Imaging Sciences, Indiana University-Purdue University at Indianapolis, Indianapolis, IN.
Laura ZahodneDepartment of Psychology, University of Michigan, Ann Arbor, MI.
Alden L GrossDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Dan MungasDepartment of Neurology, University of California-Davis, Davis, CA.
Keith F WidamanGraduate School of Education, University of California Riverside, Riverside, CA.
Julie SchneiderRush Alzheimer's Disease Center, Rush University, Chicago, IL.
Johns Hopkins University · USRush University · USVA San Diego Healthcare System · USFlorey Institute of Neuroscience and Mental Health · AUIndiana University – Purdue University Indianapolis · USMassachusetts General Hospital · USMilken Institute · USRush University Medical Center · USUniversity of California, Davis · USUniversity of California, Riverside · USUniversity of Michigan–Ann Arbor · US

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI DECARLI, CHARLES · 1991 to 2020
$28.3M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Risk Factors for Cognitive Decline in African-AmericansR01AG022018 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BARNES, LISA L · 2004 to 2025
$18.2M
Characterizing the Behavior Profile of Healthy Cognitive AgingR01AG034374 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI PATRICIA A BOYLE · 2009 to 2026
$8.8M
Racial Differences in Late-Life Cognitive Decline and Risk of Alzheimer's DiseaseRF1AG022018 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BARNES, LISA L · 2016 to 2019
$6.6M
Risk Factors, Pathology, and Clinical Expressions of ADRF1AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2014 to 2014
$6.0M
Resilience Mechanisms Underlying Racial/Ethnic Disparities in Alzheimer’s DiseaseR01AG054520 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BRICKMAN, ADAM M, ZAHODNE, LAURA B · 2017 to 2021
$5.8M
Epidemiologic Study of TDP-43 Pathology in Aging and DementiaR01AG042210 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI SCHNEIDER, JULIE A. · 2012 to 2018
$2.4M
Psychosocial Protective Factors in Cognitive and Brain AgingR00AG047963 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ZAHODNE, LAURA B · 2016 to 2018
$746k
Intersection of Physiologic Frailty and Cognitive Performance in Older Adults: An Integrative Data AnalysisK01AG050699 · NIA · JOHNS HOPKINS UNIVERSITY · PI GROSS, ALDEN L. · 2016 to 2020
$648k
CSRD VA IK2 CX000938NIA NIH HHS K01 AG040192NIA NIH HHS K01 AG050699NIA NIH HHS K01 AG050823NIA NIH HHS P30 AG010129NIA NIH HHS P30 AG010161NIA NIH HHS R00 AG047963NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG022018NIA NIH HHS R01 AG034374NIA NIH HHS R01 AG042210NIA NIH HHS R01 AG054520NIA NIH HHS R13 AG030995NIA NIH HHS R21 AG047953NIA NIH HHS RF1 AG015819NIA NIH HHS RF1 AG022018
6 · The paper itself

Abstract

objectiveOur objectives were to characterize the inter-relation of known dementia-related neuropathologies in one comprehensive model and quantify the extent to which accumulation of neuropathologies accounts for the association between age and dementia.

methodsWe used data from 1,362 autopsied participants of three community-based clinicopathological cohorts: the Religious Orders Study, the Rush Memory and Aging Project, and the Minority Aging Research Study. We estimated a series of structural equation models summarizing a priori hypothesized neuropathological pathways between age and dementia risk individually and collectively.

resultsAt time of death (mean age, 89 years), 44% of our sample had a clinical dementia diagnosis. When considered individually, our vascular, amyloid/tau, neocortical Lewy body, and TAR DNA-binding protein 43 (TDP-43)/hippocampal sclerosis pathology pathways each accounted for a substantial proportion of the association between age and dementia. When considered collectively, the four pathways fully accounted for all variance in dementia risk previously attributable to age. Pathways involving amyloid/tau, neocortical Lewy bodies, and TDP-43/hippocampal sclerosis were interdependent, attributable to the importance of amyloid beta plaques in all three. The importance of the pathways varied, with the vascular pathway accounting for 32% of the association between age and dementia, wheraes the remaining three inter-related degenerative pathways together accounted for 68% (amyloid/tau, 24%; the Lewy body, 1%; and TDP-43/hippocampal sclerosis, 43%).

interpretationAge-related increases in dementia risk can be attributed to accumulation of multiple pathologies, each of which contributes to dementia risk. Multipronged approaches may be necessary if we are to develop effective therapies. Ann Neurol 2018;84:10-22.

Indexed as

Models, NeurologicalAgedAgingAmyloidAutopsyBrainCohort StudiesDementiaDNA-Binding ProteinsFemaleHumansLewy BodiesMaleNeural PathwaysNeurofibrillary TanglesNeuropathologyAmyloidDNA-Binding ProteinsTARDBP protein, humantau Proteins

Identifiers

PMID29944741
PMCPMC6119518
OpenAlexW2810507529

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.